Alpha Crest Capital Management LLC Iovance Biotherapeutics, Inc. Transaction History

Alpha Crest Capital Management LLC

  • $0
  • Q4 2022

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$9.53 - $13.11 $26,712 - $36,747
2,803 Added 22.1%
15,488 $148,000
Q2 2022

Aug 11, 2022
SELL
$6.38 - $18.33 $30,962 - $88,955
-4,853 Reduced 27.67%
12,685 $140,000
Q1 2022

May 12, 2022
BUY
$12.38 - $19.1 $22,754 - $35,105
1,838 Added 11.71%
17,538 $292,000
Q4 2021

Feb 09, 2022
BUY
$16.55 - $27.63 $70,949 - $118,449
4,287 Added 37.56%
15,700 $300,000
Q3 2021

Nov 10, 2021
BUY
$20.35 - $26.63 $232,254 - $303,928
11,413 New
11,413 $281,000
Q2 2021

Aug 12, 2021
SELL
$16.33 - $33.07 $210,656 - $426,603
-12,900 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$28.67 - $52.59 $22,936 - $42,072
800 Added 6.61%
12,900 $408,000
Q4 2020

Feb 12, 2021
BUY
$28.04 - $50.26 $30,844 - $55,286
1,100 Added 10.0%
12,100 $561,000
Q3 2020

Nov 12, 2020
BUY
$27.75 - $36.3 $305,250 - $399,299
11,000 New
11,000 $362,000
Q2 2020

Aug 12, 2020
SELL
$27.21 - $41.0 $258,495 - $389,500
-9,500 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$19.54 - $38.85 $185,630 - $369,075
9,500 New
9,500 $284,000
Q4 2019

Feb 12, 2020
SELL
$17.95 - $29.41 $215,400 - $352,920
-12,000 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$17.99 - $26.0 $215,879 - $312,000
12,000 New
12,000 $218,000

Others Institutions Holding IOVA

# of Institutions
319
Shares Held
243M
Call Options Held
3.77M
Put Options Held
1.7M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $923M
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email